Abstract:A series of new 1‐phenylsulphonyl‐2‐(1‐methylindol‐3‐yl)‐benzimidazole derivatives were designed, synthesized and evaluated as potential inhibitors of tubulin polymerization and anthropic cancer cell lines. Among them, compound 33 displayed the most potent tubulin polymerization inhibitory activity in vitro (IC50 = 1.41 μM) and strong antiproliferative activities against A549, Hela, HepG2 and MCF‐7 cell lines in vitro with GI50 value of 1.6, 2.7, 2.9 and 4.3 μM, respectively, comparable with the positive control colchicine (GI50 value of 4.1, 7.2, 9.5 and 14.5 μM, respectively) and CA‐4 (GI50 value of 2.2, 4.3, 6.4 and 11.4 μM, respectively). Simultaneously, we evaluated that compound 33 could effectively induce apoptosis of A549 associated with G2/M phase cell cycle arrest. Immunofluorescence microscopy also clearly indicated compound 33 a potent antimicrotubule agent. Docking simulation showed that compound 33 could bind tightly with the colchicine‐binding site and act as a tubulin inhibitor. Three‐dimensional‐QSAR model was also built to provide more pharmacophore understanding that could be used to design new agents with more potent tubulin assembling inhibitory activity in the future.

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Chalcone Oxime Derivatives As Potential Tubulin Polymerization Inhibitors

Design, Synthesis and Biological Evaluation of Novel Chalcone Derivatives As Antitubulin Agents.

Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity.

Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.

Synthesis, Molecular Modeling and Biological Evaluation of Guanidine Derivatives As Novel Antitubulin Agents.

Design, Synthesis, and Biological Evaluation of Chalcone‐Containing Shikonin Derivatives As Inhibitors of Tubulin Polymerization

Synthesis, Molecular Docking and Biological Evaluation of 1-Phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole Derivatives As Novel Potential Tubulin Assembling Inhibitors

Synthesis, Biological Evaluation, and Molecular Docking Studies of Resveratrol Derivatives Possessing Chalcone Moiety As Potential Antitubulin Agents.

Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities

Design, Synthesis and Biological Evaluation of a Series of Pyrano Chalcone Derivatives Containing Indole Moiety As Novel Anti-Tubulin Agents.

Synthesis, Anticancer Activity and Molecular Modeling Studies of Novel Chalcone Derivatives Containing Indole and Naphthalene Moieties As Tubulin Polymerization Inhibitors.

Synthesis, Molecular Modeling and Biological Evaluation of Dithiocarbamates As Novel Antitubulin Agents

Synthesis, Biological Evaluation and Molecular Modeling of 1,3,4-Thiadiazol-2-amide Derivatives As Novel Antitubulin Agents.

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1-Benzene Acyl-2-(1-methylindol-3-yl)-benzimidazole Derivatives As Potential Tubulin Polymerization Inhibitors

Synthesis and biological evaluation of novel indole derivatives containing sulfonamide scaffold as potential tubulin inhibitor

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents.

Synthesis, Biological Evaluation, and Molecular Docking Studies of 2,6-Dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime Derivatives As Novel Antitubulin Agents.

Synthesis and Biological Evaluation of a Series of Podophyllotoxins Derivatives As a Class of Potent Antitubulin Agents.

Design, Synthesis and Biological Evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine Derivatives As A New Class of Tubulin Polymerization Inhibitors

Synthesis and Biological Evaluation of N-alkyl-N-(4-methoxyphenyl)pyridin-2-amines As a New Class of Tubulin Polymerization Inhibitors.